[18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2003-10-31

AUTHORS

Sungeun Kim, June-Key Chung, Soon-Beom Kang, Moon-Hong Kim, Jae Min Jeong, Dong Soo Lee, Myung Chul Lee

ABSTRACT

The aim of this study was to compare the prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) with that of second-look laparotomy (SLL) in patients with advanced ovarian carcinoma following primary chemotherapy. Fifty-five patients who had undergone cytoreductive surgery and adjuvant chemotherapy for advanced ovarian carcinoma were enrolled in the study. Thirty patients underwent SLL after primary treatment (SLL group), while 25 underwent FDG PET after primary treatment without SLL (PET group). We retrospectively reviewed the medical records of the 55 patients for comparison of progression-free interval and disease-free interval between the two groups. Ovarian carcinomas recurred in 37 of the 55 patients. When the progression-free interval and the disease-free interval in patients in the PET group were compared with those in the SLL group, no significant differences were observed. The progression-free interval in the PET and SLL groups were 28.8±12.7 months and 30.6±13.7 months, respectively (P=0.29). The disease-free interval in the negative PET group was 40.5±11.6 months, and that in the negative SLL group was 48.6±12.1 months (P=0.12). In conclusion, FDG PET has a similar prognostic value to SLL, and can substitute for SLL in the follow-up of patients who have had ovarian carcinoma, especially when there is a high risk for recurrence. More... »

PAGES

196-201

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00259-003-1367-y

DOI

http://dx.doi.org/10.1007/s00259-003-1367-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1007292516

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15129701


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Analgesics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorodeoxyglucose F18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Korea", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Laparotomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ovarian Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiopharmaceuticals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reproducibility of Results", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Second-Look Surgery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sensitivity and Specificity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tomography, Emission-Computed", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cancer Research Institute, Seoul National University Hospital, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.412484.f", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea", 
            "Cancer Research Institute, Seoul National University Hospital, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Sungeun", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Research Institute, Seoul National University Hospital, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.412484.f", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea", 
            "Cancer Research Institute, Seoul National University Hospital, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chung", 
        "givenName": "June-Key", 
        "id": "sg:person.0751347234.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.412484.f", 
          "name": [
            "Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kang", 
        "givenName": "Soon-Beom", 
        "id": "sg:person.012160052074.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012160052074.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.412484.f", 
          "name": [
            "Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Moon-Hong", 
        "id": "sg:person.01102164107.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102164107.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.412484.f", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jeong", 
        "givenName": "Jae Min", 
        "id": "sg:person.01301360400.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.412484.f", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Dong Soo", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.412484.f", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Myung Chul", 
        "id": "sg:person.01337220140.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337220140.25"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00259-001-0750-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006601848", 
          "https://doi.org/10.1007/s00259-001-0750-9"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-10-31", 
    "datePublishedReg": "2003-10-31", 
    "description": "The aim of this study was to compare the prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) with that of second-look laparotomy (SLL) in patients with advanced ovarian carcinoma following primary chemotherapy. Fifty-five patients who had undergone cytoreductive surgery and adjuvant chemotherapy for advanced ovarian carcinoma were enrolled in the study. Thirty patients underwent SLL after primary treatment (SLL group), while 25 underwent FDG PET after primary treatment without SLL (PET group). We retrospectively reviewed the medical records of the 55 patients for comparison of progression-free interval and disease-free interval between the two groups. Ovarian carcinomas recurred in 37 of the 55 patients. When the progression-free interval and the disease-free interval in patients in the PET group were compared with those in the SLL group, no significant differences were observed. The progression-free interval in the PET and SLL groups were 28.8\u00b112.7 months and 30.6\u00b113.7 months, respectively (P=0.29). The disease-free interval in the negative PET group was 40.5\u00b111.6 months, and that in the negative SLL group was 48.6\u00b112.1 months (P=0.12). In conclusion, FDG PET has a similar prognostic value to SLL, and can substitute for SLL in the follow-up of patients who have had ovarian carcinoma, especially when there is a high risk for recurrence.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00259-003-1367-y", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "31"
      }
    ], 
    "keywords": [
      "second-look laparotomy", 
      "advanced ovarian carcinoma", 
      "disease-free interval", 
      "progression-free interval", 
      "ovarian carcinoma", 
      "SLL group", 
      "FDG-PET", 
      "prognostic value", 
      "primary treatment", 
      "fluorine-18 fluorodeoxyglucose positron emission tomography", 
      "PET group", 
      "fluorodeoxyglucose positron emission tomography", 
      "underwent FDG-PET", 
      "similar prognostic value", 
      "positron emission tomography", 
      "primary chemotherapy", 
      "adjuvant chemotherapy", 
      "cytoreductive surgery", 
      "medical records", 
      "high risk", 
      "patients", 
      "carcinoma", 
      "emission tomography", 
      "months", 
      "laparotomy", 
      "chemotherapy", 
      "significant differences", 
      "treatment", 
      "group", 
      "PET", 
      "interval", 
      "surgery", 
      "recurrence", 
      "tomography", 
      "risk", 
      "study", 
      "conclusion", 
      "aim", 
      "differences", 
      "records", 
      "values", 
      "substitute", 
      "comparison"
    ], 
    "name": "[18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma", 
    "pagination": "196-201", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1007292516"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-003-1367-y"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15129701"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-003-1367-y", 
      "https://app.dimensions.ai/details/publication/pub.1007292516"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_372.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00259-003-1367-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-003-1367-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-003-1367-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-003-1367-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-003-1367-y'


 

This table displays all metadata directly associated to this object as RDF triples.

236 TRIPLES      21 PREDICATES      90 URIs      80 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00259-003-1367-y schema:about N34fd069b10c24171baa4d5bb9e9a8daf
2 N3998e8b3096341d696cdf2e6314876aa
3 N412b9d766f34487d88229d78d4ab0171
4 N4a0e2b53ff5b4e848462aed4d98c14b5
5 N520482d8e11547a9a211e8f74b3cc77c
6 N54a1807ef685456dac6987e123004dec
7 N54c4ccd5b29e4483b64021af5f9271da
8 N714d17c0a26749b295724957bf033d8d
9 N76f29400d8e646aaa19b2a18805b0fe0
10 N81a2a5c1d988495788a15f44bb8e2454
11 N820be0aeb16d4558a8a60a8894197ce8
12 N8e6c4b1a7fb24a85ac99c3456fc18f65
13 N91e9e80c4cba49bfb89662ed9ab84c5e
14 N9f7d656458f244d0be4122dcc4a6ac95
15 Na1adf88743774ae5bff65e939e95f9b3
16 Na681c38cc499498c8e54f5aecbc80fea
17 Ncb4d6c19331e41398bffc3c2ef871bc8
18 Nced86185ecd848fb895d351393746a86
19 Ndc37084d82a44cc7949b0c9f8a471406
20 Ne5d15d7c320547718cbe1b696c0d8220
21 anzsrc-for:11
22 anzsrc-for:1103
23 anzsrc-for:1112
24 schema:author Nbb3c3ef5516b47789d195581abd24b21
25 schema:citation sg:pub.10.1007/s00259-001-0750-9
26 schema:datePublished 2003-10-31
27 schema:datePublishedReg 2003-10-31
28 schema:description The aim of this study was to compare the prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) with that of second-look laparotomy (SLL) in patients with advanced ovarian carcinoma following primary chemotherapy. Fifty-five patients who had undergone cytoreductive surgery and adjuvant chemotherapy for advanced ovarian carcinoma were enrolled in the study. Thirty patients underwent SLL after primary treatment (SLL group), while 25 underwent FDG PET after primary treatment without SLL (PET group). We retrospectively reviewed the medical records of the 55 patients for comparison of progression-free interval and disease-free interval between the two groups. Ovarian carcinomas recurred in 37 of the 55 patients. When the progression-free interval and the disease-free interval in patients in the PET group were compared with those in the SLL group, no significant differences were observed. The progression-free interval in the PET and SLL groups were 28.8±12.7 months and 30.6±13.7 months, respectively (P=0.29). The disease-free interval in the negative PET group was 40.5±11.6 months, and that in the negative SLL group was 48.6±12.1 months (P=0.12). In conclusion, FDG PET has a similar prognostic value to SLL, and can substitute for SLL in the follow-up of patients who have had ovarian carcinoma, especially when there is a high risk for recurrence.
29 schema:genre article
30 schema:isAccessibleForFree false
31 schema:isPartOf Nafd810d59f734562afe67d356c0c205e
32 Ne522e3967ce04d4681741ba12795f2ff
33 sg:journal.1297401
34 schema:keywords FDG-PET
35 PET
36 PET group
37 SLL group
38 adjuvant chemotherapy
39 advanced ovarian carcinoma
40 aim
41 carcinoma
42 chemotherapy
43 comparison
44 conclusion
45 cytoreductive surgery
46 differences
47 disease-free interval
48 emission tomography
49 fluorine-18 fluorodeoxyglucose positron emission tomography
50 fluorodeoxyglucose positron emission tomography
51 group
52 high risk
53 interval
54 laparotomy
55 medical records
56 months
57 ovarian carcinoma
58 patients
59 positron emission tomography
60 primary chemotherapy
61 primary treatment
62 prognostic value
63 progression-free interval
64 records
65 recurrence
66 risk
67 second-look laparotomy
68 significant differences
69 similar prognostic value
70 study
71 substitute
72 surgery
73 tomography
74 treatment
75 underwent FDG-PET
76 values
77 schema:name [18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma
78 schema:pagination 196-201
79 schema:productId N8cc2625984a04423ab49822df2e61c38
80 Nbc6d0a2e3410421fb91cacf9cf53ddcc
81 Ncc58477f4bc5498cabd858d283936266
82 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007292516
83 https://doi.org/10.1007/s00259-003-1367-y
84 schema:sdDatePublished 2022-11-24T20:50
85 schema:sdLicense https://scigraph.springernature.com/explorer/license/
86 schema:sdPublisher Nf5b6450350bb45deb4fd1092542686af
87 schema:url https://doi.org/10.1007/s00259-003-1367-y
88 sgo:license sg:explorer/license/
89 sgo:sdDataset articles
90 rdf:type schema:ScholarlyArticle
91 N0b22d8260ba745eea84dba21d09c7710 schema:affiliation grid-institutes:grid.412484.f
92 schema:familyName Lee
93 schema:givenName Dong Soo
94 rdf:type schema:Person
95 N25471ec4271f4d439665f0afc885c740 rdf:first sg:person.0751347234.39
96 rdf:rest N8e4e569a5027468984f7f4a712556703
97 N2e7eef5318d44ae2b09dcce9a7be4d40 rdf:first N0b22d8260ba745eea84dba21d09c7710
98 rdf:rest N8d2ddec8e53246c29da9d96893bfa57d
99 N34fd069b10c24171baa4d5bb9e9a8daf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Ovarian Neoplasms
101 rdf:type schema:DefinedTerm
102 N3998e8b3096341d696cdf2e6314876aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Adult
104 rdf:type schema:DefinedTerm
105 N412b9d766f34487d88229d78d4ab0171 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Sensitivity and Specificity
107 rdf:type schema:DefinedTerm
108 N4a0e2b53ff5b4e848462aed4d98c14b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Tomography, Emission-Computed
110 rdf:type schema:DefinedTerm
111 N520482d8e11547a9a211e8f74b3cc77c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Middle Aged
113 rdf:type schema:DefinedTerm
114 N54a1807ef685456dac6987e123004dec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Laparotomy
116 rdf:type schema:DefinedTerm
117 N54c4ccd5b29e4483b64021af5f9271da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Neoplasm Recurrence, Local
119 rdf:type schema:DefinedTerm
120 N714d17c0a26749b295724957bf033d8d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Follow-Up Studies
122 rdf:type schema:DefinedTerm
123 N76f29400d8e646aaa19b2a18805b0fe0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Female
125 rdf:type schema:DefinedTerm
126 N81a2a5c1d988495788a15f44bb8e2454 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Radiopharmaceuticals
128 rdf:type schema:DefinedTerm
129 N820be0aeb16d4558a8a60a8894197ce8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Fluorodeoxyglucose F18
131 rdf:type schema:DefinedTerm
132 N86271b6faf934d20b7f9f1e46b7c3d43 rdf:first sg:person.01301360400.94
133 rdf:rest N2e7eef5318d44ae2b09dcce9a7be4d40
134 N8cc2625984a04423ab49822df2e61c38 schema:name pubmed_id
135 schema:value 15129701
136 rdf:type schema:PropertyValue
137 N8d2ddec8e53246c29da9d96893bfa57d rdf:first sg:person.01337220140.25
138 rdf:rest rdf:nil
139 N8e4e569a5027468984f7f4a712556703 rdf:first sg:person.012160052074.15
140 rdf:rest N9a7b357bac9a4989941a4f10d5ebbfc1
141 N8e6c4b1a7fb24a85ac99c3456fc18f65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Second-Look Surgery
143 rdf:type schema:DefinedTerm
144 N91e9e80c4cba49bfb89662ed9ab84c5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Analgesics
146 rdf:type schema:DefinedTerm
147 N9a7b357bac9a4989941a4f10d5ebbfc1 rdf:first sg:person.01102164107.92
148 rdf:rest N86271b6faf934d20b7f9f1e46b7c3d43
149 N9f7d656458f244d0be4122dcc4a6ac95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Reproducibility of Results
151 rdf:type schema:DefinedTerm
152 Na1adf88743774ae5bff65e939e95f9b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Aged
154 rdf:type schema:DefinedTerm
155 Na681c38cc499498c8e54f5aecbc80fea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Treatment Outcome
157 rdf:type schema:DefinedTerm
158 Nafd810d59f734562afe67d356c0c205e schema:issueNumber 2
159 rdf:type schema:PublicationIssue
160 Nbb3c3ef5516b47789d195581abd24b21 rdf:first Nbc067e66b1f04a96b57087495620a056
161 rdf:rest N25471ec4271f4d439665f0afc885c740
162 Nbc067e66b1f04a96b57087495620a056 schema:affiliation grid-institutes:grid.412484.f
163 schema:familyName Kim
164 schema:givenName Sungeun
165 rdf:type schema:Person
166 Nbc6d0a2e3410421fb91cacf9cf53ddcc schema:name doi
167 schema:value 10.1007/s00259-003-1367-y
168 rdf:type schema:PropertyValue
169 Ncb4d6c19331e41398bffc3c2ef871bc8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Prognosis
171 rdf:type schema:DefinedTerm
172 Ncc58477f4bc5498cabd858d283936266 schema:name dimensions_id
173 schema:value pub.1007292516
174 rdf:type schema:PropertyValue
175 Nced86185ecd848fb895d351393746a86 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Humans
177 rdf:type schema:DefinedTerm
178 Ndc37084d82a44cc7949b0c9f8a471406 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Disease-Free Survival
180 rdf:type schema:DefinedTerm
181 Ne522e3967ce04d4681741ba12795f2ff schema:volumeNumber 31
182 rdf:type schema:PublicationVolume
183 Ne5d15d7c320547718cbe1b696c0d8220 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Korea
185 rdf:type schema:DefinedTerm
186 Nf5b6450350bb45deb4fd1092542686af schema:name Springer Nature - SN SciGraph project
187 rdf:type schema:Organization
188 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
189 schema:name Medical and Health Sciences
190 rdf:type schema:DefinedTerm
191 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
192 schema:name Clinical Sciences
193 rdf:type schema:DefinedTerm
194 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
195 schema:name Oncology and Carcinogenesis
196 rdf:type schema:DefinedTerm
197 sg:journal.1297401 schema:issn 1619-7070
198 1619-7089
199 schema:name European Journal of Nuclear Medicine and Molecular Imaging
200 schema:publisher Springer Nature
201 rdf:type schema:Periodical
202 sg:person.01102164107.92 schema:affiliation grid-institutes:grid.412484.f
203 schema:familyName Kim
204 schema:givenName Moon-Hong
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102164107.92
206 rdf:type schema:Person
207 sg:person.012160052074.15 schema:affiliation grid-institutes:grid.412484.f
208 schema:familyName Kang
209 schema:givenName Soon-Beom
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012160052074.15
211 rdf:type schema:Person
212 sg:person.01301360400.94 schema:affiliation grid-institutes:grid.412484.f
213 schema:familyName Jeong
214 schema:givenName Jae Min
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94
216 rdf:type schema:Person
217 sg:person.01337220140.25 schema:affiliation grid-institutes:grid.412484.f
218 schema:familyName Lee
219 schema:givenName Myung Chul
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337220140.25
221 rdf:type schema:Person
222 sg:person.0751347234.39 schema:affiliation grid-institutes:grid.412484.f
223 schema:familyName Chung
224 schema:givenName June-Key
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39
226 rdf:type schema:Person
227 sg:pub.10.1007/s00259-001-0750-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006601848
228 https://doi.org/10.1007/s00259-001-0750-9
229 rdf:type schema:CreativeWork
230 grid-institutes:grid.412484.f schema:alternateName Cancer Research Institute, Seoul National University Hospital, Seoul, Korea
231 Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea
232 Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea
233 schema:name Cancer Research Institute, Seoul National University Hospital, Seoul, Korea
234 Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea
235 Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea
236 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...